Company profile

Annoroad company profile

Annoroad Gene Technology, founded in 2012 with headquarters in Beijing, is a well-known enterprise in China’s genomics industry, a leading NIPT service provider in China, and a best-in-class medical genomics center in Asia, which specializes in the application of next-generation genomics in human health and life science research. Since its founding, Annoroad has been recognized with a series of prestigious designations including national high-tech enterprise, one of the pilot organizations approved by the NHFPC (National Health and Family Planning Commission) to take part in the high-throughput sequencing clinical application, one of the first gene detection technology demonstration centers approved by..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+86 10-56315326
Operating status
Active
Company type
For Profit
Employee range
00501-01000 employees
Revenue range
$1K+
Founded
2012-01-01

Headquarters

Headquarters
Caoxi, Jiangxi, China
Postal code
100176
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$105.5M
Last funding
Series C / $105.5M / 2017-11-03
Last equity funding
Series C / $105.5M
Investors
8
Lead investors
2
Founders
1
Articles
10

Founders and investors

Founders

Junbin Liang

Lead investors

Ping An VenturesShenZhen GTJA Investment Group

Investors

Guotai Junan SecuritiesNorthern Light Venture CapitalSAIF PartnersSBCVCZhengxuan Investment

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.